Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rwness
    Junior Member
    • Mar 2010
    • 6

    #1

    Assessing quality and accuracy of de novo genome assembly

    All,
    I am curious whether anyone out there has a method for assessing the quality and accuracy of de novo genome assemblies? I am currently doing in silico simulations of de novo genome assembly from a previously sequenced genome to determine the best assembly parameters (K-mer size, coverage cutoff etc) and optimal dataset (mate pair library size, coverage etc). The ultimate goal will be to use these parameters to assemble the genome of a related species, de novo.

    However, the difficulty is that after simulating the data and making a de novo assembly I don't know of any statistics or methods to compare the assembled contigs back to original sequence that they were simulated from. This requires two steps
    (1) align assembled contigs to reference genome
    (2) assess the fit

    People often optimize N50, assembly size, contig number and other length-based measurements - but this only makes for bigger and bigger contigs and there is little information about whether these contigs are accurate. I have been using BLAST to compare the contigs to the reference and asking how well they fit, how long the alignments are and how many mis-assembled contigs there are. If anyone has ideas or methods for assessing the accuracy ( or overall similarity of an assembly and a genome) I would be grateful to hear about it. - Rob
  • nickloman
    Senior Member
    • Jul 2009
    • 355

    #2
    Good questions - I don't think there is a simple or single answer at this point.

    This paper suggests a potential metric


    You might be interested in the recently announced Assemblathon
    Mabosplay: Temukan cara daftar, login mudah, dan link alternatif terbaru Mabosplay. Ikuti panduan praktis ini agar pengalaman bermain online semakin aman & nyaman!

    Comment

    • bckirkup
      Member
      • Jan 2011
      • 17

      #3
      To check assemblies...

      ... you need an external truth. We are using 'optical mapping' from OpGen, for example. Any sort of physical map or some kinds of PCR can be used, however, depending on the size of the genomes. You can't rely on other genomes.

      For some microbes, things like skew can help you get a sense of whether your assemblies seem wrong, but they aren't necessarily a solid confirmation one way or the other.

      Comment

      • rwness
        Junior Member
        • Mar 2010
        • 6

        #4
        Originally posted by bckirkup View Post
        ... you need an external truth. We are using 'optical mapping' from OpGen, for example. Any sort of physical map or some kinds of PCR can be used, however, depending on the size of the genomes. You can't rely on other genomes.

        For some microbes, things like skew can help you get a sense of whether your assemblies seem wrong, but they aren't necessarily a solid confirmation one way or the other.
        Sorry I think I was unclear - what I am doing is simulating short read data from a species with a sequenced genome. Then trying to do de novo assembly of that simulated data. Then I want to compare my assemblies to the original genome to see how well the assemblies performed. It is similar to just testing the quality of short read genome assemblers. However, my ultimate goal is to use what I have learned in this species to apply to de novo assembly of another, related species with NO previously sequenced genome. I am trying to find a good method/metric to assess the quality of those simulated assemblies.
        Nickloman's comments are helpful, but I haven't yet been able to read the first paper that was recommended.

        Comment

        • flxlex
          Moderator
          • Nov 2008
          • 412

          #5
          This paper (interesting read otherwise) describes some metrics, I guess there will be other papers with yet more ways of getting quality metrics. Feels like we should develop a consensus...

          Comment

          • azroger
            Junior Member
            • Oct 2010
            • 7

            #6
            I don't think there is any one metric for genome assembly quality. Obviously, size matters, but so does representation (how much of the genome sequence is actually covered), mismatch rate, indel rate, and misassembly rate. All these quality metrics are derived relatively easily for a known standard genome, when you use simulated reads extracted from it. Check out www.plantagora.org, for more information on the whole question. That's what it's focus is - simulated read assembly to evaluate a lot of different sequencing and assembly approaches. The project uses a long list of metrics for evaluation of the assemblies (so you can decide which are most important to you).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 02:55 AM
            0 responses
            1 view
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Working...